S023 Nail Symposium
DESCRIPTION
This session provides the most comprehensive up-to-date information on diagnosis and treatment of major nail disorders. Recognized experts from around the world will discuss the most current scientific evidence regarding onychomycosis, nail unit psoriasis, nail unit lichen planus, nail unit squamous cell carcinoma, nail unit melanoma, nail disorders in skin of color patients, onychoscopy, advanced nail imaging, as well as other key nail topics.
LEARNING OBJECTIVES
Describe the most up to date therapy for patients with nail psoriasis.
Manage patients with onychomycosis and terbinafine resistance.
Describe the most up to date information on the treatment of nail unit melanoma.
SCHEDULE
9:00 AM
Advances in the Diagnosis of Nail Unit Tumors
Dong-Youn Lee, MD, PhD, IFAAD
9:10 AM
Update on Nail Disorders in Skin of Color
Brian William Morrison, MD, MSc, FAAD
9:20 AM
Surgical and Non-Surgical Management of Ingrown Nails
Jorge Ocampo-Garza, MD, IFAAD
9:30 AM
Expert Post-Surgical Nail Care: Ensuring Optimal Healing
Judith Dominguez-Cherit, MD
9:40 AM
Preventing and Managing Nail Surgical Complications
Bertrand Richert, MD, PhD, IFAAD
9:50 AM
Questions and Answers
Judith Dominguez-Cherit, MD, Dong-Youn Lee, MD, PhD, IFAAD, Brian William Morrison, MD, MSc, FAAD, Jorge Ocampo-Garza, MD, IFAAD, Bertrand Richert, MD, PhD, IFAAD
10:00 AM
Approach to Melanonychia
Adam Rubin, MD, FAAD
10:10 AM
Management of Pediatric Melanonychia
Je-Ho Mun, MD, PhD
10:20 AM
State of the Art Management of Nail Unit Melanoma
Nathaniel J. Jellinek, MD, FAAD
10:30 AM
Modern Evaluation and Treatment of Nail Unit Squamous Cell Carcinoma
Julia O'Brien Baltz, MD, FAAD
10:40 AM
State of the Art Understanding of Nail Toxicities from Cytotoxic and Targeted Therapies
Angela Juan Jiang, MD, FAAD
10:50 AM
Questions and Answers
Adam Rubin, MD, FAAD, Julia O'Brien Baltz, MD, FAAD, Nathaniel J. Jellinek, MD, FAAD, Angela Juan Jiang, MD, FAAD, Je-Ho Mun, MD, PhD
11:00 AM
High-Yield Onychoscopy: Key Findings to Master
Bianca Maria Piraccini, MD, IFAAD
11:10 AM
Advanced Nail Unit Imaging
Matilde Iorizzo, PhD, MD, IFAAD
11:20 AM
State of the Art Management of Nail Unit Psoriasis
Shari Lipner, MD, PhD, FAAD
11:30 AM
State of the Art Treatment of Nail Unit Lichen Planus
Molly A. Hinshaw, MD, FAAD
11:40 AM
Diagnosis and Treatment of Onychomycosis in a World with Resistant Fungi
Avner Shemer, MD, IFAAD
11:50 AM
Questions and Answers
Molly A. Hinshaw, MD, FAAD, Matilde Iorizzo, PhD, MD, IFAAD, Shari Lipner, MD, PhD, FAAD, Bianca Maria Piraccini, MD, IFAAD, Avner Shemer, MD, IFAAD
DIRECTOR
Adam Rubin, MD, FAAD
NYU Grossman School of Medicine
SPEAKERS
Julia O'Brien Baltz, MD, FAAD
Judith Dominguez-Cherit, MD
Molly A. Hinshaw, MD, FAAD
University of Wisconsin School of Medicine and Public Health
Matilde Iorizzo, PhD, MD, IFAAD
Private Dermatology Practice, Lugano/Bellinzona (Switzerland)
Nathaniel J. Jellinek, MD, FAAD
Adult and Pediatric Dermatology
Angela Juan Jiang, MD, FAAD
Oregon Health & Science University
Dong-Youn Lee, MD, PhD, IFAAD
Samsung Medical Center Sungkyunkwan University
Brian William Morrison, MD, MSc, FAAD
Je-Ho Mun, MD, PhD
Jorge Ocampo-Garza, MD, IFAAD
Bianca Maria Piraccini, MD, IFAAD
Piraccini Medical Center, Bologna Italy
Bertrand Richert, MD, PhD, IFAAD
Avner Shemer, MD, IFAAD
DISCLOSURES
Julia O'Brien Baltz, MD, FAAD
No financial relationships exist with ineligible companies.
Judith Dominguez-Cherit, MD
No financial relationships exist with ineligible companies.
Molly A. Hinshaw, MD, FAAD
BiaCure Therapies Inc – Founder(Stock); Elucent Medical – Stockholder Private Company(No Compensation Received); RevOps – Stockholder Private Company(No Compensation Received);
Matilde Iorizzo, PhD, MD, IFAAD
AbbVie – Investigator(Fees); Almirall – Speaker(Fees); Johnson and Johnson – Advisory Board(Fees); Laboratoires Bailleul – Advisory Board(Fees); Leo Pharma – Advisory Board(Fees); Springer Publishing – Other(Other Financial Benefit); Takeda Pharmaceuticals USA Inc – Advisory Board(Fees);
Nathaniel J. Jellinek, MD, FAAD
No financial relationships exist with ineligible companies.
Angela Juan Jiang, MD, FAAD
No financial relationships exist with ineligible companies.
Dong-Youn Lee, MD, PhD, IFAAD
No financial relationships exist with ineligible companies.
Brian William Morrison, MD, MSc, FAAD
No financial relationships exist with ineligible companies.
Je-Ho Mun, MD, PhD
No financial relationships exist with ineligible companies.
Jorge Ocampo-Garza, MD, IFAAD
No financial relationships exist with ineligible companies.
Bianca Maria Piraccini, MD, IFAAD
Difa Cooper – Consultant (1099 relationship)(Honoraria); Eli Lilly – Advisory Board(Fees); Giuliani Pharma – Consultant (1099 relationship)(Honoraria); L'Oréal France – Advisory Board(Fees); Pfizer Inc. – Consultant (1099 relationship)(Honoraria); Pierre Fabre Dermo Cosmetique France – Advisory Board(Fees);
Bertrand Richert, MD, PhD, IFAAD
No financial relationships exist with ineligible companies.
Adam Rubin, MD, FAAD
New York University Langone Medical Center – Employee – Lab does not sell products(Salary);
Avner Shemer, MD, IFAAD
No financial relationships exist with ineligible companies.